Epix contrast agent allows clearer MRI images:
This article was originally published in Clinica
Epix Medical's AngioMark contrast agent gives clear three dimensional magnetic resonance images of the heart in patients allowed to breathe normally, early feasibility studies have shown. The results of the Phase II studies on six patients were presented at the Society for Cardiovascular Magnetic Resonance in Atlanta, Georgia in January. Residual movement of the chest wall increased the level of artefacts in the images. Delineation of the coronary vessels was good and "long portions of the left and right coronary systems could be visualised with sub-millimetre resolution", said the researchers.
You may also be interested in...
South Korea’s HLB has begun a new growth phase by taking over US-based clinical stage biotech firm Immunomic Therapeutics. Through the acquisition, it is poised to add new pipeline assets including a Phase II vaccine therapy for glioblastoma and proprietary lysosomal targeting technology.
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.